Pirtobrutinib and BTK Inhibitors in the CLL Treatment Landscape
Pharmacy Times,
Image credit: jarun011 | stock.adobe.com Précis This review discusses the prevalence, mechanisms of development, and evolving…
Image credit: jarun011 | stock.adobe.com Précis This review discusses the prevalence, mechanisms of development, and evolving…
Dive Brief: The Food and Drug Administration told Merck KGaA not to give an experimental drug for multiple sclerosis to new…
Summary Overview of Curis, including key partnerships, balance sheet, and recent stock price.
Patients with chronic lymphocytic leukemia (CLL) who received treatment with single-agent acalabrutinib (Calquence) experienced…
Patients with chronic lymphocytic leukemia who received treatment with single-agent acalabrutinib experienced a low incidence…
Summary APTO's lead candidate, CG-806, is due for important updates in 4Q2020. CG-806 is a unique molecule attempting to enter…
. Jun 16 · 7 min read Originally published Jan 07, 2020 How do you catch just one kind of fish in a sea of similar fish? That’s…
8.24am BST 08:24 AstraZeneca shares jump on Covid-19 trial plan Shares in pharmaceuticals giant AstraZeneca have surged 6…
How do you catch just one kind of fish in a sea of similar fish? That’s the question being answered by researchers at Nurix…